Advertisement

Current Treatment Options in Gastroenterology

, Volume 3, Issue 4, pp 295–302 | Cite as

Functional gastroesophageal reflux disease (GERD)

  • Kenneth R. DeVault
  • Sami R. Achem
Article

Opinion statement

  • Lack of endoscopic esophagitis does not exclude gastroesophageal reflux disease (GERD).

  • Ambulatory pH testing is also an imperfect standard, and patients with both a normal endoscopy and a normal pH test may still have symptoms produced by acid reflux.

  • A therapeutic trial of acid suppression is often the best approach to these patients.

  • Ideally, therapeutic trials should use a medication with a high degree of efficacy in the treatment of GERD to avoid a false-negative test.

  • Proton pump inhibitors (PPIs) are the best currently available medical therapy for all forms of GERD.

  • If the patient does not respond to a once daily PPI, options include increasing the dose of PPIs, and, perhaps, adding another class of agent or studying the patient with an ambulatory pH test.

  • Patients with a negative endoscopy, negative pH test. and those who do not respond to an adequate trial of acid suppression are unlikely to benefit from antireflux surgery.

Keywords

Irritable Bowel Syndrome Omeprazole Esophagitis Cisapride Gastroesophageal Reflux Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Tefera L, Fein M, Ritter MP, et al.: Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease? Am Surg 1997, 63:933–936.PubMedGoogle Scholar
  2. 2.
    Lauritsen K, Aalykke C, Havelund T, et al.: Effect of omeprazole in functional dyspepsia: a double-blind, randomized, placebo-controlled study. Gastroenterology 1996, 110:A702.Google Scholar
  3. 3.
    Pace F, Santalucia F, Bianchi PG: Natural history of gastroesophageal reflux disease without esophagitis. Gut 1991, 32:845–848.PubMedGoogle Scholar
  4. 4.
    Mattox HE, Richter JE: Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease. Am J Med 1990, 89:345–356.PubMedCrossRefGoogle Scholar
  5. 5.
    Weiner GJ, Morgan TM, Copper JB, et al.: Ambulatory 24 hour esophageal pH monitoring: reproducibility and variability of pH parameters. Dig Dis Sci 1988, 33:1127–1133.CrossRefGoogle Scholar
  6. 6.
    Schlesinger PK, Donahue PE, Schmidt B, Layden TJ: Limitations of 24 hour intraesophageal pH monitoring in the hospital setting. Gastroenterology 1985, 89:797–804.PubMedGoogle Scholar
  7. 7.
    Murphy DW, Yuan Y, Castell DO: Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci 1989, 34:649–656.PubMedCrossRefGoogle Scholar
  8. 8.
    Tew S, Jamieson GG, Pilowski I, Myers J: The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis. Dis Esophagus 1997, 10:9–15.PubMedGoogle Scholar
  9. 9.
    Bradley LA, Richter JE, Pulliam TJ, et al.: The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 1993, 8:11–19.Google Scholar
  10. 10.
    Johnston BT, Lewis SA, Love AHG: Stress, personality and social support in gastro-oesophageal reflux disease. J Psychosom Res 1995, 39:221–226.PubMedCrossRefGoogle Scholar
  11. 11.
    Langeluddecke P, Goulston K, Tennant C: Psychological factors in dyspepsia of unknown cause: a comparison with peptic ulcer disease. J Psychosom Res 1990, 34:215–222.PubMedCrossRefGoogle Scholar
  12. 12.
    Watson RG, Tham TC, Johnston BT, McDougall NI: Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux: the sensitive esophagus. Gut 1997, 40:587–590. The above study is an important trial of acid suppression in a group of patients with reflux symptoms without endoscopic or pH abnormalities. This study indicated that many of these patients will respond to reflux therapy.PubMedGoogle Scholar
  13. 13.
    Trimble KC, Douglas S, Pryde A, Heading RC: Clinical characteristics and natural history of symptomatic but not excessive gastroesophageal reflux. Dig Dis Sci 1995, 40:1098–1104.PubMedCrossRefGoogle Scholar
  14. 14.
    Constantini M, Sturniolo GC, Zaninoto G, et al.: Altered esophageal pain thresholds in irritable bowel syndrome. Dig Dis Sci 1993, 38:206–212.CrossRefGoogle Scholar
  15. 15.
    Smart HL, Nicholson DA, Atkinson M: Gastro-oesophageal reflux in the irritable bowel syndrome. Gut 1986, 27:1227–1131.Google Scholar
  16. 16.
    Ericksen CA, Cullen PT, Suton D, et al.: Abnormal esophageal transit in patients with typical reflux symptoms, but normal endoscopic and pH profiles. Am J Surg 1991, 161:657–661.CrossRefGoogle Scholar
  17. 17.
    Kahrilas PJ: Dysfunction of the belch reflex: a cause of incapacitating chest pain. Gastroenterology 1987, 93:818–822.PubMedGoogle Scholar
  18. 18.
    Achem SR, Kolts BE, MacMath T, et al.: Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997, 42:2138–2145.PubMedCrossRefGoogle Scholar
  19. 19.
    Gotley DC, Morgan AP, Cooper JB: Bile acid concentrations in the refluxate of patients with reflux esophagitis. Br J Surg 1988, 75:587–590.PubMedCrossRefGoogle Scholar
  20. 20.
    Howard PJ, Maher L, Pryde A, Heading RC: Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure and mucosal acid sensitivity are three separate, though related aspects of gastro-oesophageal reflux disease. Gut 1991, 32:128–132.PubMedGoogle Scholar
  21. 21.
    McDougall NI, Johnston BT, Collins JSA, et al.: Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis. Eur J Gastroenterol Hepatol 1997, 9:1161–1167.PubMedGoogle Scholar
  22. 22.
    Marrero JM, DeCaestcker JS, Maxwell JD: Effect of famotidine on oesophageal sensitivity in gastrooesophageal reflux disease. Gut 1994, 35:447–450.PubMedGoogle Scholar
  23. 23.
    Spechler SJ: Gastroesophageal reflux disease. Curr Treat Options Gastroenterol 1998, 1:40–48.PubMedGoogle Scholar
  24. 24.
    DeVault KR, Castell DO: Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 1999, 94:1434–1442. Guidelines for the treatment of all forms of GERD approved by the major GI societies.PubMedCrossRefGoogle Scholar
  25. 25.
    Carlsson R, Dent J, Watts R, et al.: Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Euro J Gastroenterol Hepatol 1998, 10:119–124.CrossRefGoogle Scholar
  26. 26.
    Bate CM, Griffin SM, Keeling PW, et al.: Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 1996, 10:547–555. Trial confirming the ability of PPI therapy to control symptoms in those patients without esophagitis.PubMedCrossRefGoogle Scholar
  27. 27.
    Lind T, Havelund T, Carlsson R, et al.: Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997, 32:974–979. Trial that provides additional conformation to reference 26.PubMedCrossRefGoogle Scholar
  28. 28.
    Havelund T, Aalykke C: The efficacy of a pectin-based raft-forming agent in endoscopy-negative reflux disease. Scand J Gastroenterol 1997, 32:773–777.PubMedGoogle Scholar
  29. 29.
    Robinson M, Decktor DL, Stone RC, et al.: Famotidine (20 mg) bd. relieves gastro-oesophageal reflux symptoms in patients without erosive oesophagitis. Aliment Pharmacol Ther 1991, 5:631–643.CrossRefGoogle Scholar
  30. 30.
    Blom H: Omeprazole vs ranitidine in the management of patients with heartburn. Gastroenterology 1997, 112:A73.CrossRefGoogle Scholar
  31. 31.
    Galmiche JP, Barthelemy P, Hameline B: Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997, 11:765.PubMedCrossRefGoogle Scholar
  32. 32.
    Carlsson R, Dent J, Watts R, et al.: Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 1998, 10:119–124.PubMedCrossRefGoogle Scholar
  33. 33.
    Spechler SJ: Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesopahgeal Reflux Study Group. N Engl J Med 1992, 326:786–792.PubMedCrossRefGoogle Scholar
  34. 34.
    Lundell L, Dalenvack J, Hattlevakk J, et al.: Omeprazole or antireflux surgery in the long term management of gastroesophageal reflux disease: results of a multicentre, randomized, clinical trail. Gastroenterology 1998, 114:A207.CrossRefGoogle Scholar
  35. 35.
    Weerts JM, Dallemagne B, Harmoir E, et al.: Laparoscopic Nissen Fundoplication: Detailed analysis of 132 patients. Surg Laprosc Endosc 1993, 3:359–364.Google Scholar
  36. 36.
    Bammer T, Freeman M, Shahriare A, et al.: The surgical outcome of laparoscopic anti-reflux surgery in patients with endoscopy negative gastroesophageal reflux disease. Gastroenterology 1998, 116:A107.Google Scholar

Copyright information

© Current Science Inc 2000

Authors and Affiliations

  • Kenneth R. DeVault
    • 1
  • Sami R. Achem
    • 1
  1. 1.Mayo Clinic JacksonvilleJacksonvilleUSA

Personalised recommendations